Novo Holdings' indtjening blev næsten halveret i 2018

Mens Novo Holdings formår at score gevinster på sine aktiver i Novo Nordisk og Novozymes, så er afkastet fra life science-investeringerne og de finansielle investeringer dårligere end sidste år og derfor er indtjeningen næsten halveret.
Photo: Novo Holdings/PR
Photo: Novo Holdings/PR

Sidste års aktieuro har sat sine tydelige spor i investeringsselskabet Novo Holdings' resultater.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading

The environmental, social and governance ratings of exchange-traded funds are set to be downgraded by index provider MSCI. | Foto: Delcia Lopez/AP/Ritzau Scanpix

Hundreds of funds set to lose ESG rating